Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients

Journal of Clinical Periodontology

Volumn 34, Issue 4, 2007, Pages 271-277

  Lappin, David F ^a   Sherrabeh, Sakhr ^a   Jenkins, William M M ^a   Macpherson, Lorma M D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Health; OPG; Periodontitis; RANKL; Smoking

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PERIODONTITIS; PREVENTIVE DENTISTRY; SMOKING;

ADULT; ALVEOLAR BONE LOSS; CASE-CONTROL STUDIES; DENTAL PROPHYLAXIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PERIODONTITIS; RANK LIGAND; SMOKING;

EID: 33947306303     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2007.01048.x     Document Type: Article

References (39)

1. Ainamo, J. & Ainamo, A. (1996) Risk assessment of recurrence of disease during supportive periodontal care. Epidemiological considerations. Journal of Clinical Periodontohgy 23, 232-239.
2. Amano, S., Kawakami, K., Iwahashi, H., Kitano, S. & Hanazawa, S. (1997) Functional role of endogenous CD14 in lipopolysaccharide-stimulated bone resorption. Journal of Cellular Physiology 173, 301-309.
3. Anderson, M. A., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M.C., DuBose, R. F., Cosraan, D. & Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.
4. Benson, B. W. & Shulman, J. D. (2005) Inclusion of tobacco exposure as a predictive factor for decreased bone mineral content. Nicotine Tobacco Research 7, 719-724.
5. Bergström, J. (2003) Tobacco smoking and risk for periodontal disease. Journal of Clinical Periodontology 30, 107-113.
6. Corral, D. A., Amling, M., Priemel, M., Loyer, E., Fuchs, S., Ducy, P., Baron, R. & Karsenty, G. (1998) Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proceeding of the National Academy of Sciences of the United States of America 95, 13835-13840.
7. Crotti, T., Smith, M. D., Hirsch, R., Soukoulis, S., Weedon, H., Capone, M., Ahern, M. J. & Haynes, D. (2003) Receptor activator NF kappa B ligand (RANKL) and osteoproteger-in (OPG) protein expression in periodontitis. Journal of Periodontal Research 38, 380-387.
8. de Vries, T. J., Schoenmaker, T., Wattanaroonwong, N., van den Hoonaard, M., Nieuwenhuijse, A., Beertsen, W. & Everts, V. (2006) Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts. Journal of Cell Biochemistry 98, 370-382.
9. Eastcott, J. W., Yamashita, K., Taubman, M. A., Harada, Y. & Smith, D. J. (1994) Adoptive transfer of cloned T helper cells ameliorates periodontal disease in nude rats. Oral Microbiology Immunology 9, 284-289.
10. Feldmann, M., Brennan, F. M. & Maini, R. N. (1996) Role of cytokines in rheumatoid arthritis. Annual Review of Immunology 85, 307-310.
11. Fukushima, H., Kajiya, H., Takada, K., Okamoto, F. & Okabe, K. (2003) Expression and role of RANKL in periodontal ligament cells during physiological root-resorption in human deciduous teeth. European Journal of Oral Science 111, 346-352.
12. Fuller, K., Wong, B., Fox, S., Choi, Y. & Chambers, T. J. (1998) TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. Journal of Experimental Medicine 188, 997-1001.
13. Garlet, G. P., Cardoso, C. R., Silva, T. A., Ferreira, B. R., Avila-Campos, M. J., Cunha, F. Q. & Silva, J. S. (2006) Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiology Immunology 21, 12-20.
14. Garlet, G. P., Martins, W. Jr., Fonseca, B. A., Ferreira, B. R. & Silva, J. S. (2004) Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. Journal of Clinical Periodontology 31, 671-679.
15. Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J. & Riggs, B. L. (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. Journal of Bone Mineral Research 15, 2-12.
16. Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H. L., Elliott, G., Kelley, M. J., Sarosi, I., Wang, L., Xia, X. Z., Elliott, R., Chiu, L., Black, T., Scully, S., Capparelli, C., Morony, S., Shimamoto, G., Bass, M. B. & Boyle, W. J. (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegrein ligand. Proceedings of the National Academy of Sciences of the United States of America 96, 3540-3545.
17. Johnson, G. K. & Hill, M. (2004) Cigarette smoking and the periodontal patient. Journal of Periodontology 75, 196-209.
18. Johnson, J. D. (1994) Smokers have less dense bones and fewer teeth. Journal of the Royal Society on Health 114, 265-269.
19. Kawai, T., Eisen-Lev, R., Seki, M., Eastcott, J. W., Wilson, M. E. & Taubman, M. A. (2000) Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. Journal of Immunology 164, 2102-2109.
20. Kawashima, N. & Stashenko, P. (1999) Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Archives of Oral Biology 44, 55-66.
21. Kikuchi, T., Matsuguchi, T., Tsuboi, N., Mitani, A., Tanaka, S., Matsuoka, M., Yamamoto, G., Hishikawa, T., Noguchi, T. & Yoshikai, Y. (2001) Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. Journal of Immunology 166, 3574-3579.
22. Kotake, S., Udagawa, N., Hakoda, M., Mogi, M., Yano, K., Tsuda, E., Takahashi, K., Furuya, T., Ishiyama, S., Kim, K. J., Saito, S., Nishikawa, T., Takahashi, N., Togari, A., Tomatsu, T., Suda, T. & Kamatani, N. (2001) Activated human cells directly induce osteo-clastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis and Rheumatism 44, 1003-1012.
23. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J. & Boyle, W. J. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
24. Lamichhane, A. P. (2005) Osteoporosis-an update. Journal of the Nepal Medical Association 44, 60-66.
25. Liu, D., Xu, J. K., Figliomeni, L., Pavlos, N. J., Rogers, M., Tan, A., Price, P. & Zheng, M. H. (2002) Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. International Journal of Molecular Medicine 11, 17-22.
26. Mogi, M., Otogoto, J., Ota, N. & Togari, A. (2004) Differential expression of RANKL and osteoprotegerin in gingival cervicular fluid of patients with periodontitis. Journal of Dental Research 83, 166-169.
27. Page, R. C. (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. Journal of Clinical Research 26, 230-242.
28. Sato, N., Takahashi, N., Suda, K., Nakamura, M., Yamaki, M., Ninomiya, T., Kobayashi, Y., Takada, H., Shibata, K., Yamaraoto, M., Takeda, K., Akira, S., Noguchi, T. & Udagawa, N. (2004) MyD88 but not TRIP is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-lalpha. Journal of Experimental Medicine 200, 601-611.
29. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Luthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H. L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T. M., Hill, D., Pattison, W., Campbell, P. & Boyle, W. J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319.
30. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. & Martin, T. J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Reviews 20, 345-357.
31. Tanaka, H., Tanabe, N., Shoji, M., Suzuki, N., Katono, T., Sato, S., Motohashi, M. & Maeno, M. (2006) Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts. Life Sciences 78, 1733-1740.
32. Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508.
33. Terpos, E., Szydlo, R., Apperley, J. F., Hitjiharissi, E., Politou, M., Meletis, J., Viniou, N., Yataganas, X., Goldman, J. M. & Rahemtulla, A. (2003) Soluble receptor activator of nuclear factor kappa B ligand- osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood 102, 1064-1069.
34. Van Dyke, T. E. & Sheilesh, D. (2005) Risk factors for periodontitis. Journal of the International Academy of Periodontology 7, 3-7.
35. White, S. C., Atchison, K. A., Gornbein, J. A., Nattiv, A., Paganini-Hill, A. & Service, S. K. (2006) Risk factors for fractures in older men and women: the leisure world cohort study. Gender Medicine 3, 110-123.
36. Yamashita, T., Takahashi, N, Yang, S., Sato, N, & Udagawa, N. (2006) Bone destruction caused by osteoclasts. Clinical Calcium 16, 10-16.
37. Yang, S., Takahashi, N., Yamashita, T., Sato, N., Takahashi, M., Mogi, M., Uematsu, T., Kobayashi, Y., Nakamichi, Y., Takeda, K., Akira, S., Takada, H., Udagawa, N. & Furusawa, K. (2006) Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. Journal of Immunology 175, 1956-1964.
38. Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S. I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T. & Higashio, K. (1998b) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139, 1329-1337.
39. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. & Suda, T. (1998a) Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America 95, 3597-3602.